Article Text

Download PDFPDF

OP-016 French prioritization of infectious diseases: necessity to consider children’s needs
  1. Minodier Philippe1,
  2. Haas Hervé2,
  3. Basmaci Romain3,
  4. Vié Le Sage François4,
  5. Bakhache Pierre2,
  6. Ouziel Antoine2,
  7. Thollot Franck2,
  8. Brehin Camille2,
  9. Cahn Sellem Fabienne4,
  10. Thiebault Georges4,
  11. Floreani Sylvie1,
  12. Alexandre Mathilde1,
  13. Ventelou Bruno1,
  14. Henry Sabine1,
  15. Pozzetto Bruno1,
  16. Hoen Bruno1,
  17. Ploin Dominique1
  1. 1Commission Spécialisée Maladies Infectieuses et Maladies Émergentes (CS-MIME), Haut Conseil de la santé publique, Paris, France
  2. 2Groupe de Pathologie Infectieuse Pédiatrique (GPIP), Nice, France
  3. 3Société Française de Pédiatrie (SFP), Paris, France
  4. 4Association Française de Pédiatrie Ambulatoire (AFPA), Croissy sur Seine, France


Aim The French High Council of Public Health (HCPH) was asked by the Ministry of Health to draw up a list of priority infectious diseases in metropolitan France and its overseas territories.

Material and Method Multi-criteria decision analysis (MCDA) was used, as recommended by the ECDC. A list of 95 entities (diseases or groups of infectious diseases) was drawn up, and 10 assessment criteria were defined: potential for emergence and spread, incidence, lethality, individual impact, societal impact, impact on vulnerable populations, impact on the health system, unmet needs for prevention, therapeutic tools, and health surveillance. The criteria were weighted by a multidisciplinary panel of 77 HCPH-experts. Then, a panel of 98 physicians from 8 specialties rated each disease according to the criteria using a 4-point rating scale through an online questionnaire.

Results Fifteen of the 95 entities were ranked as high priorities: 14 were known diseases such as viral hemorrhagic fevers, various respiratory viral infections, arboviral infections, antibiotic-multiresistant bacterial infections, invasive meningococcal and pneumococcal infections, prion diseases, rabies, and tuberculosis; ‘Disease X’ ranked highest (figure 1). Out of 98 physicians, 11 pediatricians participated (61% response rate), and their 513 entity-ratings represented 11% of the total.

Abstract OP-016 Figure 1

Involvement of the different prioritization criteria in determining the score of the 14 high-priority entities. E1: Viral hemorrhagic fevers, E2: Acute respiratory infections due to viruses other than influenza, emerging coronaviruses, RSV and hMPV, E3: Mosquito-borne arboviruses, E4: Influenza virus infections with zoonotic potential, E5: Seasonal influenza A and B, E6: Emerging coronavirus infections (Severe Acute Respiratory Syndrome, Middle-East Respiratory Syndrome, COVID-19), E7: Respiratory syncytial virus and human metapneumovirus respiratory infections, E8: Creutzfeldt- Jakob disease and other human transmissible spongiform encephalopathies, E9: Systemic infections due to multi-resistant bacteria to antibiotics, E10: Infections due to emerging highly- resistant bacteria to antibiotics, E11: Invasive infections due to Neisseria meningitidis, E12: Rabies, E13: Tuberculosis due to antibiotic-susceptible strains, E14: Invasive pneumococcal disease. Simulated ratings for Disease X ranged between 59.4 and 75.4.

Conclusions The ECDC-MCDA made it possible to establish a list of priority infectious diseases in a relatively short period of time. Adaptability of the method allowed to consider the specificities of France, mainland and overseas. Most priority infectious risks are well covered by national surveillance and warning systems. The participation of pediatricians in this study was necessary to take into account the specific pediatric burden and thus to defend the needs of children when orienting the priority social means in the field of infectious diseases (surveillance, health organization, and research).

  • France/epidemiology
  • Communicable Diseases/epidemiology
  • Health Priorities
  • Public Health
  • Multi-criteria decision analysis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.